Table 2 Nucleotide and amino acid sequence differences between the complete genome sequences of VHSV strains MI03 and DK-3592B

3′ leader

2/53, (3.77%)

N gene 5’UTR

6/111, (5.40%)

N gene ORF

134/1212, (11.06%)

29/404, (7.18%)

N gene 3′ UTR

30/60, (50.0%)

20 nt

N-P intergenic

0/2 (CG)

P gene 5’UTR

7/57, (12.28%)

1 nt

P gene ORF

98/666, (14.71%)

15/222, (6.76%)

P gene 3′ UTR

6/34, (17.65%)

P-M intergenic

0/2 (CG)

M gene 5’UTR

13/81, (16.05%)

M gene ORF

68/603, (11.28%)

9/201, (4.48%)

M gene 3′ UTR

12/54, (22.22%)

1 nt

M-G intergenic

0/2 (TG)

G gene 5’UTR

7/33, (21.21%)

G gene ORF

205/1521, (13.48%)

37/507, (7.30%)

G gene 3′ UTR

12/51, (23.53%)

G-NV intergenic

0/2 (TG)

NV gene 5’UTR

6/21, (28.57%)

NV gene ORF

79/366, (21.58%)

32/122, (26.23%)

NV gene 3′ UTR

6/31, (19.35%)

NV-L intergenic

0/2 (TG)

L gene 5’UTR

11/94, (11.70%)

L gene ORF

760/5952, (12.77%)

66/1984, (3.33%)

L gene 3′ UTR

9/38, (23.68%)

2 nt

5′ trailer

23/116 (19.83%)

1 nt

Full Genome

1489/11184 (13.31%)

25 nt total